StockWatch
·

Indo Farm Equipment Ltd

BSE: 544328

P/L Snapshot

Q1 FY27 · standalone

vs Q4 FY26·vs Q1 FY26
Revenue
105.84
-18.3%+14.3%
Expenditure
98.78
-16.2%+14.6%
Net Profit
5.06
-38.5%+10.3%
OPM %
11.61%
-1.23pp+0.11pp

Shareholding

Pattern breakdown

P/L Trends

(in crores)

RevenueExpenditureNet Profit
0.0036.2772.54108.81145.09Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27
Price Chart
Reports

Tractor surge masks crane halt, margins compressed

capacity expansion · dealer bottleneck · margin recovery

TranscriptDeep diveQ1 FY2717 Aug 20266 minAutomobile

Indo Farm Q1FY27: consolidated PAT +4% YoY, margins compress despite 14.5% revenue growth

farm equipment · tractors · cranes

ResultsQ1 FY2708 Aug 20263 minAutomobile
Latest
Board Meeting8 Aug, 6:21 pm

Indo Farm Q1FY27: consolidated PAT +4% YoY, margins compress despite 14.5% revenue growth

Indo Farm Equipment's consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 14.5% YoY to ₹110.24 Cr, but consolidated PAT grew just 4.1% YoY to ₹5.66 Cr (basic EPS ₹1.18 vs ₹1.13) — profit growth lagging revenue growth on both fronts. Sequentially, revenue fell 17.7% and PAT fell 35.1% versus Q4 FY26 (₹133.99 Cr / ₹8.72 Cr), which is largely seasonal: farm-equipment demand is stronger in the January-March window ahead of the sowing season, so the QoQ drop should not be read as a slowdown signal on its own — the YoY read is the one that matters, and it shows margin erosion, not just softer sequential demand. The compression shows up on both lines: consolidated NPM (PAT/total income) fell to 5.08% from 5.54% a year ago and 6.45% last quarter; operating margin (EBIT ex-other-income/revenue) slipped to 13.12% from 13.68% YoY and 13.90% QoQ. Cost of materials (+15.9%), employee costs (+17.5%) and other expenses (+23.6%) all grew faster than the 14.5% topline, squeezing the operating line even as finance costs actually fell YoY (₹4.05 Cr vs ₹4.41 Cr). Segment-wise the growth mix is lopsided: tractor revenue jumped 36.3% YoY to ₹52.08 Cr, well ahead of management's 25-30% FY27 guidance pace, while crane revenue was flat at ₹52.86 Cr (-0.4% YoY) against a 15-20% guided growth rate — consistent with the new pick-and-carry and tower crane capacities not yet being commercial. The NBFC subsidiary Barota Finance, now broken out as its own segment, added ₹5.31 Cr of revenue and ₹2.27 Cr of segment profit, lifting consolidated PBT ₹0.78 Cr above the standalone figure. Against management's own May 2026 guidance of 20-25% FY27 revenue growth and a ~12.5% FY27 EBITDA margin, the quarter tracks below the revenue growth rate (14.5% YoY) though the operating margin (13.12%) still sits above the full-year target — for now. No Q1-specific street estimates could be found; a prior FY27 outlook piece (Univest) cited a full-year analyst PAT growth expectation of roughly 15-20%, which this quarter's 4.1% YoY PAT growth trails, though a single quarter is not directly comparable to a full-year estimate. No management press release accompanied this filing beyond the standard board-outcome letter, so there is no fresh commentary to reconcile against the numbers. The quarter's other disclosed developments — the August 8 board meeting itself, the routine appointment of an internal auditor, and the AGM notice for FY26 — are procedural and don't bear on the print. What this sets up: management's own Q2 FY27 markers (pick-and-carry crane commercial production at 30-35% initial utilization, tower crane production at 50-60% utilization) are the next checkpoints — if cranes stay flat past Q2 despite the new lines going live, the FY27 20-25% revenue guidance comes under real pressure given tractors alone would need to keep compounding at a 36%+ clip to compensate. Of the ₹70.07 Cr earmarked from IPO proceeds for the crane capacity expansion, ₹44.67 Cr remains unutilized as of June 30, 2026.

8 Aug 2026, 06:21 pm

Corporate Events

Board MeetingINDOFARM
2026
23Sep

Board Meeting

To receive, consider and adopt the Audited Standalone and Co…

BSE Filing
Board MeetingINDOFARM
2026
8Aug

Board Meeting

The meeting of the Board of Directors is scheduled to consid…

BSE Filing
Board MeetingINDOFARM
2025
12Nov

Board Meeting

Consider and approve Intimation of Board Meeting, consider a…

BSE Filing
Board MeetingINDOFARM
2025
28May

Board Meeting

Consider and approve Intimation of Board Meeting, Disclosure…

BSE Filing
Board MeetingINDOFARM
2025
13Feb

Board Meeting

Board Meeting Intimation, Consider, approve and take on reco…

BSE Filing